These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18025093)

  • 21. Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.
    van Lier CJ; Sha J; Kirtley ML; Cao A; Tiner BL; Erova TE; Cong Y; Kozlova EV; Popov VL; Baze WB; Chopra AK
    Infect Immun; 2014 Jun; 82(6):2485-503. PubMed ID: 24686064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel autotransporter adhesin is required for efficient colonization during bubonic plague.
    Lawrenz MB; Lenz JD; Miller VL
    Infect Immun; 2009 Jan; 77(1):317-26. PubMed ID: 18936182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence.
    Felek S; Krukonis ES
    Infect Immun; 2009 Feb; 77(2):825-36. PubMed ID: 19064637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early emergence of Yersinia pestis as a severe respiratory pathogen.
    Zimbler DL; Schroeder JA; Eddy JL; Lathem WW
    Nat Commun; 2015 Jun; 6():7487. PubMed ID: 26123398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasiveness of the Yersinia pestis ail protein contributes to host dissemination in pneumonic and oral plague.
    Zhang Y; Ying X; He Y; Jiang L; Zhang S; Bartra SS; Plano GV; Klena JD; Skurnik M; Chen H; Cai H; Chen T
    Microb Pathog; 2020 Apr; 141():103993. PubMed ID: 31988008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
    Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
    Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague.
    Cathelyn JS; Crosby SD; Lathem WW; Goldman WE; Miller VL
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13514-9. PubMed ID: 16938880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
    Lemaître N; Sebbane F; Long D; Hinnebusch BJ
    Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc transporters YbtX and ZnuABC are required for the virulence of Yersinia pestis in bubonic and pneumonic plague in mice.
    Bobrov AG; Kirillina O; Fosso MY; Fetherston JD; Miller MC; VanCleave TT; Burlison JA; Arnold WK; Lawrenz MB; Garneau-Tsodikova S; Perry RD
    Metallomics; 2017 Jun; 9(6):757-772. PubMed ID: 28540946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.
    Lee-Lewis H; Anderson DM
    Infect Immun; 2010 Jan; 78(1):220-30. PubMed ID: 19841077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague.
    Tidhar A; Flashner Y; Cohen S; Levi Y; Zauberman A; Gur D; Aftalion M; Elhanany E; Zvi A; Shafferman A; Mamroud E
    PLoS One; 2009 Sep; 4(9):e7023. PubMed ID: 19759820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sequence analysis of the yadA, inv, and ail genes and their expression in the main and nonmain Yersinia pestis subspecies and Yersinia pseudotuberculosis].
    Eroshenko GA; Odinokov GN; Kukleva LM; Krasnov IaM; Kutyrev VV
    Genetika; 2010 Jun; 46(6):734-41. PubMed ID: 20734763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.
    Demeure CE; Dussurget O; Mas Fiol G; Le Guern AS; Savin C; Pizarro-Cerdá J
    Genes Immun; 2019 May; 20(5):357-370. PubMed ID: 30940874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague.
    Hinnebusch BJ; Jarrett CO; Callison JA; Gardner D; Buchanan SK; Plano GV
    Infect Immun; 2011 Dec; 79(12):4984-9. PubMed ID: 21969002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation.
    Pechous RD; Broberg CA; Stasulli NM; Miller VL; Goldman WE
    mBio; 2015 Feb; 6(1):e02302-14. PubMed ID: 25691593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.
    Zauberman A; Tidhar A; Levy Y; Bar-Haim E; Halperin G; Flashner Y; Cohen S; Shafferman A; Mamroud E
    PLoS One; 2009 Jun; 4(6):e5938. PubMed ID: 19529770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis.
    Bland DM; Eisele NA; Keleher LL; Anderson PE; Anderson DM
    PLoS One; 2011 Mar; 6(3):e17352. PubMed ID: 21399698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
    Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathionylation of
    Mitchell A; Tam C; Elli D; Charlton T; Osei-Owusu P; Fazlollahi F; Faull KF; Schneewind O
    mBio; 2017 May; 8(3):. PubMed ID: 28512097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.
    Olson RM; Dhariwala MO; Mitchell WJ; Anderson DM
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.